Effect of cytokine-induced killer cells combined with dendritic cells on the survival rate and expression of 14-3-3ζ and p-Bad proteins in Lewis lung cancer cell lines

被引:5
|
作者
Hou, Yang [1 ]
Zang, Dongyu [2 ]
Li, Xiaoming [3 ]
Li, Fuzhi [2 ]
机构
[1] Jinzhou Med Univ, Life Sci Inst, Jinzhou 121001, Liaoning, Peoples R China
[2] Jinzhou Med Univ, Affiliated Hosp 3, Dept Thoraxes Surg, 40 Sect 3,Songpo Rd, Jinzhou 121001, Liaoning, Peoples R China
[3] Jinzhou Med Univ, Dept Histol & Embryol, Jinzhou 121001, Liaoning, Peoples R China
关键词
cytokine-induced killer cells; dendritic cells; Lewis lung cancer cell; phosphorylated-Bad; PHOSPHO-BAD; IMMUNOTHERAPY; APOPTOSIS; PHOSPHORYLATION; COMBINATION; ABLATION; THERAPY; VACCINE;
D O I
10.3892/ol.2018.8834
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the present study, the function and mechanism of cytokine-induced killer cells (CIK) combined with dendritic cells (DC-CIK) were examined in Lewis lung cancer (LLC) cells. Co-culture of CIK dendritic cells (DC) in vitro was used to investigate their proliferation and the antitumor effects on LLC cells. DC and CIK cells were collected from healthy human peripheral blood mononuclear cells and co-cultured as an experimental group, while LLC cells were cultured alone as a control group. Cell morphology was observed by an inverted microscope and an MTT assay was utilized to detect the proliferation of LLC cells. Expression of 14-3-3 and p-Bad were measured by western blot analysis. Compared with the control group, treatment of LLC cells with DC-CIK resulted in decreased cell adherence, reduced cell proliferation and abnormal morphological changes. Additionally, DC-CIK treatment of LLC cells resulted in the decreased expression of 14-3-3 and p-Bad protein in LLC cells, which may provide important information pertaining to the possible mechanism of DC-CIK-induced antitumor activity against LLC cells. The present study provides a theoretical and experimental basis for the clinical treatment of DC-CIK cell co-culture.
引用
收藏
页码:1815 / 1820
页数:6
相关论文
共 40 条
  • [21] Efficacy of dendritic cell-cytokine induced killer cells combined with concurrent chemoradiotherapy on locally advanced non-small cell lung cancer
    Tian, Lin
    Wang, Wei
    Yu, Bin
    Zhang, Guoxia
    JOURNAL OF BUON, 2020, 25 (05): : 2364 - 2370
  • [22] Effectiveness and Safety of Chemotherapy Combined with Dendritic Cells Co-Cultured with Cytokine-Induced Killer Cells in the Treatment of Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Han, Rui-xian
    Liu, Xu
    Pan, Pan
    Jia, Ying-jie
    Yu, Jian-chun
    PLOS ONE, 2014, 9 (09):
  • [23] Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment
    Xie, Yunqing
    Huang, Lijie
    Chen, Luchuan
    Lin, Xiaowei
    Chen, Li
    Zheng, Qiuhong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
  • [24] Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment
    Yunqing Xie
    Lijie Huang
    Luchuan Chen
    Xiaowei Lin
    Li Chen
    Qiuhong Zheng
    World Journal of Surgical Oncology, 15
  • [25] Effects of a gemcitabine plus platinum regimen combined with a dendritic cell-cytokine induced killer immunotherapy on recurrence and survival rate of non-small cell lung cancer patients
    Zhao, Min
    Li, Hongbing
    Li, Lei
    Zhang, Yijie
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 7 (05) : 1403 - 1407
  • [26] Chemotherapy plus dendritic cells co-cultured with cytokine-induced killer cells versus chemotherapy alone to treat advanced non-small-cell lung cancer: A meta-analysis
    Zhou, Cuiling
    Liu, Donglan
    Li, Jie
    Sun, Huanhuan
    Zheng, Xiaobin
    Wang, Shuncong
    Hong, Guobin
    Mallampati, Saradhi
    Sun, Hongliu
    Zhou, Xiuling
    Cheng, Zhibin
    Zhang, Hongyu
    Ma, Haiqing
    ONCOTARGET, 2016, 7 (52) : 86500 - 86510
  • [27] The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV Non-small cell lung cancer
    Li, Liuning
    Liu, Jiaying
    Chai, Xiaoshu
    Zhang, Liwen
    Chen, Zhijian
    He, Chunxia
    Hong, Hongxi
    2014 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE (BIBM), 2014,
  • [28] 2003-2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancer
    Lin, Mao
    Liang, Shuzhen
    Jiang, Feng
    Xu, Jiongyuan
    Zhu, Weibing
    Qian, Wei
    Hu, Yong
    Zhou, Zhanchun
    Chen, Jibing
    Niu, Lizhi
    Xu, Kecheng
    Lv, Youyong
    IMMUNOLOGY LETTERS, 2017, 183 : 37 - 43
  • [29] A Combination of Cytokine-Induced Killer Cells With PD-1 Blockade and ALK Inhibitor Showed Substantial Intrinsic Variability Across Non-Small Cell Lung Cancer Cell Lines
    Li, Yutao
    Sharma, Amit
    Wu, Xiaolong
    Weiher, Hans
    Skowasch, Dirk
    Essler, Markus
    Schmidt-Wolf, Ingo G. H.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [30] Immunological and clinical effects of post-surgical adjuvant chemotherapy and immunotherapy using autologous dendritic cells (DCs) induced cytokine-induced killer (CIK) cells for non-small-cell lung cancer (NSCLC) patients
    Li, Hui
    CANCER RESEARCH, 2009, 69